Erschienen in:
01.12.2014
Downregulation of Insulin-like growth factor binding protein 6 is associated with ACTH-secreting pituitary adenoma growth
verfasst von:
Yakun Yang, Miaomiao Sheng, Fengming Huang, Dechao Bu, Xiaohai Liu, Yong Yao, Congxin Dai, Bowen Sun, Jindong Zhu, Yonghui Jiao, Zhenqing Wei, Huijuan Zhu, Lin Lu, Yi Zhao, Chengyu Jiang, Renzhi Wang
Erschienen in:
Pituitary
|
Ausgabe 6/2014
Einloggen, um Zugang zu erhalten
Abstract
Background
Adrenocorticotrophic hormone (ACTH)-dependent Cushing’s syndrome, called Cushing disease, is caused by a corticotroph tumor of the pituitary gland. Insulin-like growth factor binding protein 6 (IGFBP6), which regulates insulin-like growth factor (IGF) activity and inhibits several IGF2-dependent cancer growths, plays a pivotal role in the tumorigenesis of malignancy, but its roles in ACTH-secreting pituitary adenomas remain unclear.
Objective
To investigate IGFBP6 expression in ACTH-secreting pituitary adenomas, and its involvement in tumor growth.
Methods
Sporadic ACTH-secreting pituitary adenomas specimens (n = 41) and adjacent non-tumorous pituitary tissues (n = 9) were collected by transphenoidal surgery. IGFBP6 expression was assessed by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and validated by Western blotting. Associations of IGFBP6 expression with maximum tumor diameter or Ki-67 labeling index were evaluated in ACTH-secreting pituitary adenomas.
Results
IGFBP6 mRNA and protein expression were both decreased in ACTH-secreting pituitary adenomas, compared to adjacent non-tumorous pituitary tissues (P < 0.01). IGFBP6 expression was correlated inversely with maximum tumor diameter (Rho = −0.53, P < 0.0001) and Ki-67 levels (Rho = −0.52, P < 0.05). Moreover, IGFBP6 downregulation activated PI3 K-AKT-mTOR pathway in ACTH-secreting pituitary adenomas.
Conclusions
IGFBP6 attenuation in ACTH-secreting pituitary adenomas is associated with tumor growth, through activation of PI3K-AKT-mTOR pathway. The finding underlies IGFBP6 roles in Cushing disease and would potentially provide a novel target of medical therapies.